|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5297 USD | -0.02% |
|
+3.86% | +17.71% |
| 06/04 | Zivo Bioscience Inc Signs Manufacturing Agreement with Cyanotech Corporation for Zivolife Algal Biomass | CI |
| 12/11 | Cyanotech Corporation, Q2 2026 Earnings Call, Nov 11, 2025 |
| Market Cap | 2.17M 1.91M 1.77M 1.63M 3.06M 210M 3.11M 21.08M 8.25M 103M 8.16M 7.99M 355M | P/E 2024 |
-0.36x | P/E 2025 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 13.48M 11.81M 10.97M 10.08M 18.99M 1.3B 19.27M 131M 51.13M 637M 50.61M 49.52M 2.2B | EV / Sales 2024 |
0.53x | EV / Sales 2025 | 0.57x |
| Free-Float |
67.23% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Cyanotech Corporation
| 1 day | -0.02% | ||
| 1 week | +3.86% | ||
| Current month | +22.02% | ||
| 1 month | +35.82% | ||
| 3 months | +36.13% | ||
| 6 months | +32.42% | ||
| Current year | +17.71% |
| 1 week | 0.39 |  | 0.53 |
| 1 month | 0.39 | | 0.53 |
| Current year | 0.23 | | 0.55 |
| 1 year | 0.21 | | 0.57 |
| 3 years | 0.12 | | 1.04 |
| 5 years | 0.12 | | 3.95 |
| 10 years | 0.12 | | 6.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Custer
CEO | Chief Executive Officer | 43 | 16/06/2022 |
Gerald Cysewski
CEO | Chief Executive Officer | 77 | 31/03/2016 |
| Director of Finance/CFO | 46 | 21/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Mulder
BRD | Director/Board Member | 65 | 17/05/2016 |
David Vied
BRD | Director/Board Member | 65 | 27/01/2015 |
Matthew Custer
BRD | Director/Board Member | 43 | 16/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/9/25 | Free | Chief Financial Officer | 50,000 | 0.6987% | ||
| 28/8/25 | Free | Director | 50,000 | 0.6987% | ||
| 28/8/25 | Free | Director | 50,000 | 0.6987% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.02% | +3.86% | +26.15% | -41.59% | 3.84M | |
| +1.95% | +1.29% | +48.23% | +157.82% | 1,037B | |
| +1.40% | +3.76% | +53.38% | +51.60% | 615B | |
| +1.50% | +1.20% | +35.10% | +79.79% | 448B | |
| +5.14% | +5.40% | +33.75% | +27.79% | 326B | |
| +1.85% | +3.57% | +37.09% | +40.59% | 293B | |
| -0.11% | +0.48% | +18.87% | +17.70% | 264B | |
| +0.25% | -4.62% | -27.66% | -41.76% | 216B | |
| +0.32% | -1.12% | +18.82% | +56.07% | 198B | |
| -0.27% | -4.76% | +14.31% | +67.15% | 162B | |
| Average | +1.19% | +1.00% | +25.80% | +41.52% | 355.74B | |
| Weighted average by Cap. | +1.63% | +1.47% | +35.27% | +75.81% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 23.07M 20.21M 18.77M 17.24M 32.49M 2.23B 32.97M 224M 87.5M 1.09B 86.61M 84.74M 3.76B | 24.22M 21.22M 19.7M 18.1M 34.11M 2.34B 34.61M 235M 91.84M 1.14B 90.9M 88.94M 3.95B |
| Net income | -5.27M -4.61M -4.28M -3.94M -7.42M -508M -7.53M -51.04M -19.98M -249M -19.77M -19.35M -859M | -3.2M -2.81M -2.61M -2.39M -4.51M -309M -4.58M -31.04M -12.15M -151M -12.02M -11.76M -522M |
| Net Debt | 10.2M 8.93M 8.29M 7.62M 14.36M 984M 14.57M 98.81M 38.67M 481M 38.28M 37.45M 1.66B | 11.31M 9.91M 9.2M 8.45M 15.93M 1.09B 16.16M 110M 42.88M 534M 42.45M 41.53M 1.84B |
Employees
83
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/07/26 | USD 0.5297 | -0.02% | 12,014 |
| 20/07/26 | USD 0.5298 | -0.02% | 1,532 |
| 16/07/26 | USD 0.5299 | +3.90% | 4,905 |
| 15/07/26 | USD 0.5100 | -3.76% | 200 |
| 14/07/26 | USD 0.5299 | +8.14% | 1,125 |
- Stock Market
- Stocks
- CYAN Stock
Select your edition
All financial news and data tailored to specific country editions
